primary biliary cirrhosis

Showing 1 - 25 of 66

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

TruGraf Liver Gene Expression Serial Test

Not yet recruiting
  • Autoimmune Liver Disease
  • +3 more
  • TruGraf®
  • (no location specified)
Sep 27, 2023

Genetic Epidemiology of Primary Biliary Cirrhosis (PBC)

Active, not recruiting
  • Primary Biliary Cirrhosis
  • Genetic Analysis
  • Rochester, Minnesota
    Mayo Clinic
Jan 9, 2023

sCD163 in PBC Patients - Assessment of Treatment Response

Recruiting
  • Primary Biliary Cirrhosis
  • +2 more
  • Blood samples
  • +3 more
  • Aarhus C, Region Midtjylland, Denmark
    Department of Hepatology and Gastroenterology, Aarhus University
Aug 11, 2022

Primary Biliary Cirrhosis Trial in Edmonton (Mind-body intervention with 1-1 support from study personnel)

Completed
  • Primary Biliary Cirrhosis
  • Mind-body intervention with 1-1 support from study personnel
  • Edmonton, Alberta, Canada
    University of Alberta
Aug 2, 2022

Primary Biliary Cholangitis, Primary Biliary Cirrhosis, Cholangitis Trial in United States (HTD1801 (BUDCA))

Completed
  • Primary Biliary Cholangitis
  • +5 more
  • HTD1801 (BUDCA)
  • Miami, Florida
  • +11 more
Jun 24, 2022

Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

Recruiting
  • Rare Disorders
  • +309 more
    • Sioux Falls, South Dakota
    • +1 more
    Jun 20, 2022

    Primary Biliary Cirrhosis Trial in Worldwide (Elafibranor 80mg, Placebo)

    Recruiting
    • Primary Biliary Cirrhosis
    • Elafibranor 80mg
    • Placebo
    • Chandler, Arizona
    • +114 more
    Apr 6, 2022

    Primary Biliary Cirrhosis Trial in Edmonton (Mind-body therapy)

    Active, not recruiting
    • Primary Biliary Cirrhosis
    • Mind-body therapy
    • Edmonton, Alberta, Canada
      University of Alberta
    Apr 1, 2022

    Primary Sclerosing Cholangitis, Primary Biliary Cirrhosis, Cholangiocarcinoma Trial in Rochester

    Recruiting
    • Primary Sclerosing Cholangitis
    • +3 more
      • Rochester, Minnesota
        Mayo Clinic
      Feb 22, 2022

      Primary Biliary Cirrhosis Trial in Beijing (Fenofibrate, UDCA)

      Withdrawn
      • Primary Biliary Cirrhosis
      • Beijing, China
        Beijing 302 hospital
      Sep 12, 2021

      Primary Biliary Cirrhosis Trial in Changchun (Obeticholic Acid Tablets, UDCA, Placebo)

      Recruiting
      • Primary Biliary Cirrhosis
      • Obeticholic Acid Tablets
      • +2 more
      • Changchun, Jilin, China
        The first hospital of Jilin University
      Jul 23, 2021

      Autoimmune Hepatitis, Primary Biliary Cirrhosis Trial in Chengdu (Methylprednisolone and Mycophenolate mofetil,

      Recruiting
      • Autoimmune Hepatitis
      • Primary Biliary Cirrhosis
      • Methylprednisolone and Mycophenolate mofetil
      • Methylprednisolone and azathioprine
      • Chengdu, Sichuan, China
        West China Hospital of Sichuan Univerisity
      Jun 18, 2021

      Primary Biliary Cirrhosis Trial in Aarhus N (Thiamine, Placebo)

      Recruiting
      • Primary Biliary Cirrhosis
      • Aarhus N, Region Midtjylland, Denmark
        Department of Hepatology and Gastroenterology, Aarhus University
      May 19, 2021

      Primary Biliary Cirrhosis Trial in Worldwide (Obeticholic Acid (OCA), Placebo)

      Completed
      • Primary Biliary Cirrhosis
      • Obeticholic Acid (OCA)
      • Placebo
      • Sacramento, California
      • +58 more
      Apr 9, 2021

      Primary Biliary Cirrhosis Trial in Puebla (Bezafibrate 200 MG Oral Tablet, Placebo, Ursodeoxycholic Acid)

      Unknown status
      • Primary Biliary Cirrhosis
      • Bezafibrate 200 MG Oral Tablet
      • +2 more
      • Puebla, Mexico
        Instituto Mexicano de Seguro Social
      Feb 9, 2021

      Primary Biliary Cirrhosis Trial in Astana (Sublimated mare milk, Ursodeoxycholic Acid)

      Completed
      • Primary Biliary Cirrhosis
      • Sublimated mare milk
      • Ursodeoxycholic Acid
      • Astana, Kazakhstan
        National Research Medical Center
      Jan 23, 2021

      Primary Biliary Cirrhosis Trial in United States (Saroglitazar magnesium 2 mg, Saroglitazar magnesium 4 mg, Placebo Oral Tablet)

      Completed
      • Primary Biliary Cirrhosis
      • Saroglitazar magnesium 2 mg
      • +2 more
      • Pasadena, California
      • +8 more
      Jan 3, 2021

      Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity

      Completed
      • SCAD
      • +28 more
        • Rochester, Minnesota
          Mayo Clinic
        Nov 20, 2020

        Bezafibrate in Patients With Primary Biliary Cholangitis (PBC)

        Recruiting
        • Primary Biliary Cirrhosis
        • Blood sampling
        • +2 more
        • Aarhus N, Region Midtjylland, Denmark
        • +1 more
        Nov 3, 2020

        Primary Biliary Cirrhosis Trial in Sacramento (abatacept)

        Completed
        • Primary Biliary Cirrhosis
        • abatacept
        • Sacramento, California
          Univeristy of California Davis Medical Center
        Mar 28, 2020

        Primary Biliary Cirrhosis Trial in Changchun (TQA3526, Placebo to match TQA3526)

        Not yet recruiting
        • Primary Biliary Cirrhosis
        • Changchun, Jilin, China
          The first hospital of Jilin University
        Feb 18, 2020

        Primary Biliary Cirrhosis Trial in Paris, Bonn (budesonide, budesonide )

        Terminated
        • Primary Biliary Cirrhosis
        • Paris, France
        • +1 more
        Jan 27, 2020

        Primary Biliary Cirrhosis Trial in Guangzhou (total response Group)

        Completed
        • Primary Biliary Cirrhosis
        • total response Group
        • Guangzhou, Guangdong, China
          The Third Affiliated Hospital of Sun Yat-sen University
        Dec 23, 2019

        Primary Biliary Cirrhosis Trial in Aarhus (Obeticholic acid, Placebos)

        Completed
        • Primary Biliary Cirrhosis
        • Obeticholic acid
        • Placebos
        • Aarhus, Denmark
          Susanne Keiding
        Oct 31, 2019

        Repeatability and Reproducibility of Quantitative MRCP

        Completed
        • Primary Sclerosing Cholangitis
        • +3 more
        • MRCP+
        • Cambridge, Cambridgeshire, United Kingdom
        • +1 more
        Aug 26, 2019